Cardiogenesis Corp., an Irvine medical device maker, is looking to a twist on its core product to help weather a rough spot. That is if the Food and Drug Administration approves it. Cardiogenesis is ...

Irvine-based Cardiogenesis Corp. is being bought for $22 million by CryoLife Inc., the companies said Tuesday. Cardiogenesis, which had sales of $11.3 million last year, makes devices used to treat ...

Atlanta-based CryoLife has inked a deal to buy Cardiogenesis Corporation for $22 million--a 43 percent premium to Cardiogenesis' closing price on March 28. The Irvine, CA-based developer makes ...

Lake Forest, CA - Shareholders of Eclipse Surgical Technologies, Inc, the California company that specializes in cardiac angiogenesis, voted last week to change its name to CardioGenesis Corporation.

Shares of CardioGenesis Corp., a Foothill Ranch medical device company specializing in the treatment of cardiovascular disease, started trading Thursday on Nasdaq’s national market system under the ...

CardioGenesis Corp., a Foothill Ranch maker of angina-relieving devices, said Thursday that it has promoted veteran senior executive Darrell F. Eckstein to president and chief operating officer, ...

NEW YORK (CBS.MW) -- Shares of CardioGenesis plummeted below $1 Thursday for the first time since early January after the company suffered a setback in efforts to win U.S. regulatory approval for a ...

This press release is available in German. Many different tissues and organs form from pluripotent stem cells during embryonic development. To date it had been known that these processes are ...

NEW YORK (CBS.MW) -- Shares of Cardiogenesis plummeted more than 36 percent to 66 cents in morning action after the company suffered a setback in its efforts to win U.S. regulatory approval for its ...

It has recently been brought to our attention that some of the lanes in the reverse-transcriptase-mediated polymerase chain reaction (RT–PCR) analyses of this Letter appear to be duplicated.